APA (7th ed.) Citation

Bashari, W. A., van der Meulen, M., MacFarlane, J., Gillett, D., Senanayake, R., Serban, L., . . . Gurnell, M. (2022). 11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy. Pituitary, 25(4), 573-586. https://doi.org/10.1007/s11102-022-01229-9

Chicago Style (17th ed.) Citation

Bashari, W. A., et al. "11C-methionine PET Aids Localization of Microprolactinomas in Patients with Intolerance or Resistance to Dopamine Agonist Therapy." Pituitary 25, no. 4 (2022): 573-586. https://doi.org/10.1007/s11102-022-01229-9.

MLA (9th ed.) Citation

Bashari, W. A., et al. "11C-methionine PET Aids Localization of Microprolactinomas in Patients with Intolerance or Resistance to Dopamine Agonist Therapy." Pituitary, vol. 25, no. 4, 2022, pp. 573-586, https://doi.org/10.1007/s11102-022-01229-9.